SUMMARY
Conclusions. It has been proved that, together with the existence of significant strategic advantages in the implementation of socially responsible activities by pharmaceutical companies, this activity has a significant list of risks. These risks it is necessary to identify, reveal, estimate and operate them for increase in efficiency of social responsibility of pharmaceutical business. It was revealed that a certain range of risks of social responsibility are not manageable, they cannot be avoided, and their existence is due to the natural laws of the development of the pharmaceutical business and the desire of pharmaceutical companies to improve their own reputation and competitiveness. That is, today, for every pharmaceutical company that goes along the path of social responsibility, it is necessary to use modern methodological tools to identify, assess and manage the risks of social responsibility of the pharmaceutical business to ensure the conditions of sustainable socio-economic development.